Trial Profile
Pharmacokinetics of everolimus and enteric-coated mycophenolate sodium before and after withdrawal of cyclosporine in stable renal transplant patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2007
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Everolimus (Primary) ; Mycophenolate sodium (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 01 Nov 2007 Status changed from recruiting to completed.
- 02 May 2007 New trial record.